ロード中...
How Often Do Safety Signals Occur by Chance in First‐in‐Human Trials?
Clinicians working on first‐in‐human clinical studies need to be able to judge whether safety signals observed on an investigational drug were more likely to have occurred by chance or to have been caused by the drug. We retrospectively reviewed 84 Novartis studies including 1,234 healthy volunteers...
保存先:
| 出版年: | Clin Transl Sci |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6132364/ https://ncbi.nlm.nih.gov/pubmed/29702733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12558 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|